Vault-13

AIGH Capital Management LLC

BALTIMORE, MD · CIK 1835943 · 13F filing filed 2026-08-07

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.1bn reported value +126.2% vs Q1 2026
42positions
73.8%in top 10
16 new 9 added 16 reduced 14 sold out vs Q1 2026

Options: 1 call positions ($9.0m notional), 2 put positions ($473.2m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SANDISK CORP COM SNDK SNDK 149,000 $338.8m30.67% 30.67% ReducedShares held: Q3 2025 280.0k, Q4 2025 280.0k, Q1 2026 200.0k, Q2 2026 149.0k -51.0k -51,000 -25.5%
2 MAXLINEAR INC COM MXL MXL 818,000 $104.7m9.48% 9.48% NewShares held: Q3 2025 1.1m, Q4 2025 0, Q1 2026 0, Q2 2026 818.0k
3 INTEL CORP COM INTC INTC 623,500 $87.1m7.88% 7.88% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 623.5k
4 DIGITAL TURBINE INC COM NEW APPS APPS 6,548,450 $84.5m7.65% 7.65% AddedShares held: Q3 2025 1.5m, Q4 2025 0, Q1 2026 4.9m, Q2 2026 6.5m +1.7m +1,652,678 33.8%
5 SILICON MOTION TECHNOLOGY CO SPONSORED ADR SIMO SIMO 144,000 $48.0m4.35% 4.35% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 144.0k -56.0k -56,000 -28.0%
6 CLEARFIELD INC COM CLFD CLFD 1,008,469 $40.1m3.63% 3.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
7 METHODE ELECTRS INC COM MEI MEI 1,678,409 $31.8m2.88% 2.88% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.7m
8 AMTECH SYS INC COM PAR $0.01N ASYS ASYS 1,252,000 $28.9m2.62% 2.62% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
9 FENNEC PHARMACEUTICALS INC COM FENC FENC 2,486,038 $26.7m2.42% 2.42% AddedShares held: Q3 2025 681.5k, Q4 2025 1.6m, Q1 2026 2.0m, Q2 2026 2.5m +504.5k +504,537 25.5%
10 KYVERNA THERAPEUTICS INC COM KYTX KYTX 2,795,797 $24.9m2.26% 2.26% AddedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 2.0m, Q2 2026 2.8m +795.8k +795,797 39.8%
11 NYXOAH S A SHS NYXH NYXH 14,534,880 $24.6m2.22% 2.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.5m
12 PERSONALIS INC COM PSNL PSNL 1,715,000 $23.0m2.08% 2.08% ReducedShares held: Q3 2025 3.9m, Q4 2025 2.9m, Q1 2026 2.9m, Q2 2026 1.7m -1.2m -1,185,000 -40.9%
13 SOPHIA GENETICS SA ORDINARY SHARES SOPH SOPH 3,954,194 $22.8m2.07% 2.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.0m
14 3-D SYS CORP DEL COM NEW DDD DDD 7,271,000 $22.0m1.99% 1.99% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 7.3m
15 VUZIX CORP COM NEW VUZI VUZI 6,745,667 $19.6m1.77% 1.77% AddedShares held: Q3 2025 898.6k, Q4 2025 0, Q1 2026 3.3m, Q2 2026 6.7m +3.4m +3,449,913 104.7%
16 ABEONA THERAPEUTICS INC COM NEW ABEO ABEO 2,987,000 $18.5m1.67% 1.67% ReducedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 3.1m, Q2 2026 3.0m -113.0k -113,000 -3.6%
17 ARDELYX INC COM ARDX ARDX 3,200,000 $16.3m1.48% 1.48% NewShares held: Q3 2025 198.5k, Q4 2025 1.1m, Q1 2026 0, Q2 2026 3.2m
18 BIODESIX INC COM BDSX BDSX 678,328 $15.3m1.38% 1.38% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 758.3k, Q2 2026 678.3k -80.0k -80,000 -10.6%
19 SPRUCE BIOSCIENCES INC COM NEW SPRB SPRB 250,000 $13.5m1.22% 1.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
20 CASTLE BIOSCIENCES INC COM CSTL CSTL 545,101 $13.0m1.18% 1.18% ReducedShares held: Q3 2025 707.3k, Q4 2025 624.7k, Q1 2026 590.6k, Q2 2026 545.1k -45.5k -45,500 -7.7%
21 VANDA PHARMACEUTICALS INC COM VNDA VNDA 2,044,169 $12.5m1.13% 1.13% ReducedShares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 2.8m, Q2 2026 2.0m -705.8k -705,831 -25.7%
22 PELTHOS THERAPEUTICS INC COM SHS PTHS PTHS 329,098 $9.3m0.84% 0.84% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 329.1k
23 POLYPID LTD COM PYPD PYPD 1,504,741 $7.6m0.69% 0.69% ReducedShares held: Q3 2025 1.1m, Q4 2025 1.3m, Q1 2026 1.6m, Q2 2026 1.5m -88.8k -88,846 -5.6%
24 VERASTEM INC COM NEW VSTM VSTM 1,927,000 $7.4m0.67% 0.67% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 1.9m -73.0k -73,000 -3.6%
25 BROADWIND INC COM NEW BWEN BWEN 1,156,000 $5.6m0.51% 0.51% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
26 AEYE INC CL A NEW LIDR LIDR 3,855,000 $5.6m0.50% 0.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.9m
27 ORTHOPEDIATRICS CORP COM KIDS KIDS 269,765 $5.2m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 269.8k
28 APYX MEDICAL CORPORATION COM APYX APYX 1,128,343 $5.1m0.46% 0.46% AddedShares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m +23.4k +23,373 2.1%
29 IDEAL PWR INC COM NEW IPWR IPWR 894,731 $4.8m0.43% 0.43% ReducedShares held: Q3 2025 513.0k, Q4 2025 492.0k, Q1 2026 1.2m, Q2 2026 894.7k -287.0k -286,965 -24.3%
30 TALPHERA INC COM NEW TLPH TLPH 4,601,502 $4.7m0.43% 0.43% ReducedShares held: Q3 2025 4.5m, Q4 2025 4.7m, Q1 2026 4.7m, Q2 2026 4.6m -60.0k -60,000 -1.3%
31 TIGO ENERGY INC COM TYGO TYGO 1,990,371 $4.6m0.42% 0.42% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 7.3m, Q2 2026 2.0m -5.3m -5,289,941 -72.7%
32 ENERGOUS CORP COM NEW WATT WATT 182,000 $4.4m0.40% 0.40% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 215.0k, Q2 2026 182.0k -33.0k -33,000 -15.3%
33 RENOVORX INC COM NEW RNXT RNXT 4,405,439 $4.3m0.39% 0.39% AddedShares held: Q3 2025 2.6m, Q4 2025 2.8m, Q1 2026 3.7m, Q2 2026 4.4m +699.2k +699,242 18.9%
34 RICHARDSON ELECTRS LTD COM RELL RELL 200,434 $3.8m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.4k
35 NEURAXIS INC COM NRXS NRXS 519,938 $3.8m0.34% 0.34% AddedShares held: Q3 2025 400.0k, Q4 2025 400.0k, Q1 2026 400.0k, Q2 2026 519.9k +119.9k +119,938 30.0%
36 COYA THERAPEUTICS INC COMMON STOCK COYA COYA 631,912 $3.7m0.33% 0.33% ReducedShares held: Q3 2025 1.1m, Q4 2025 975.4k, Q1 2026 975.4k, Q2 2026 631.9k -343.5k -343,492 -35.2%
37 IDENTIV INC COM NEW INVE INVE 1,449,121 $3.7m0.33% 0.33% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 409.2k, Q2 2026 1.4m +1.0m +1,039,935 254.2%
38 ELUTIA INC CL A COM ELUT ELUT 2,695,644 $2.6m0.24% 0.24% ReducedShares held: Q3 2025 3.2m, Q4 2025 3.1m, Q1 2026 3.6m, Q2 2026 2.7m -899.6k -899,606 -25.0%
39 APREA THERAPEUTICS INC COM NEW APRE APRE 1,015,541 $814.8k0.07% 0.07% UnchangedShares held: Q3 2025 539.3k, Q4 2025 370.5k, Q1 2026 1.0m, Q2 2026 1.0m
40 BIOFRONTERA INC COM NEW BFRI BFRI 739,910 $699.6k0.06% 0.06% ReducedShares held: Q3 2025 1.0m, Q4 2025 915.2k, Q1 2026 915.2k, Q2 2026 739.9k -175.3k -175,300 -19.1%
41 QUOIN PHARMACEUTICALS LTD SPONSORED ADS QNRX QNRX 70,000 $338.8k0.03% 0.03% AddedShares held: Q3 2025 0, Q4 2025 49.3k, Q1 2026 51.0k, Q2 2026 70.0k +19.0k +19,000 37.2%
42 NN INC COM NNBR NNBR 11,496 $41.3k0.00% 0.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 11.5k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ZEBRA TECHNOLOGIES CORPORATI ZBRA ZBRA 100,000 $20.9m100.0k shares
NLIGHT INC LASR LASR 340,000 $19.4m340.0k shares
GENERAC HLDGS INC GNRC GNRC 90,000 $17.6m90.0k shares
REGAL REXNORD CORPORATION RRX RRX 75,000 $14.0m75.0k shares
LARIMAR THERAPEUTICS INC LRMR LRMR 3,000,000 $13.5m3.0m shares
ESPERION THERAPEUTICS INC NE ESPR ESPR 4,400,000 $12.1m4.4m shares
ZEVRA THERAPEUTICS INC ZVRA ZVRA 1,200,000 $11.2m1.2m shares
INTELLICHECK INC IDN IDN 1,517,249 $10.6m1.5m shares
PROTARA THERAPEUTICS INC TARA TARA 1,622,733 $8.5m1.6m shares
BK TECHNOLOGIES CORPORATION BKTI BKTI 32,615 $2.4m32.6k shares
LIPOCINE INC NEW LPCN LPCN 200,000 $1.6m200.0k shares
LIGHTPATH TECHNOLOGIES INC LPTH LPTH 100,000 $1.0m100.0k shares
REGENTIS BIOMATERIALS LTD RGNT RGNT 300,000 $916.5k300.0k shares
SMARTKEM INC 895,449 $203.7k895.4k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ISHARES TR IWM · Put IWMPut 1,103,000 $331.4m1.1m shares Added
INVESCO QQQ TR QQQ · Put QQQPut 192,500 $141.8m192.5k shares New
DOMO INC HUCK · Call HUCKCall 2,880,000 $9.0m2.9m shares New